Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs FDC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA FDC DISHMAN PHARMA/
FDC
 
P/E (TTM) x 30.0 23.9 125.6% View Chart
P/BV x 3.3 3.5 96.0% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 DISHMAN PHARMA   FDC
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
FDC
Mar-23
DISHMAN PHARMA/
FDC
5-Yr Chart
Click to enlarge
High Rs374318 117.8%   
Low Rs129229 56.3%   
Sales per share (Unadj.) Rs197.0107.5 183.2%  
Earnings per share (Unadj.) Rs21.211.7 181.4%  
Cash flow per share (Unadj.) Rs34.714.0 247.4%  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs179.9119.5 150.6%  
Shares outstanding (eoy) m80.70165.91 48.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.32.5 50.2%   
Avg P/E ratio x11.923.4 50.7%  
P/CF ratio (eoy) x7.319.5 37.2%  
Price / Book Value ratio x1.42.3 61.1%  
Dividend payout %9.40-   
Avg Mkt Cap Rs m20,30745,368 44.8%   
No. of employees `000NANA-   
Total wages/salary Rs m5,3553,909 137.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,89817,838 89.1%  
Other income Rs m265512 51.8%   
Total revenues Rs m16,16318,350 88.1%   
Gross profit Rs m4,1032,496 164.4%  
Depreciation Rs m1,091389 280.1%   
Interest Rs m94441 2,310.7%   
Profit before tax Rs m2,3342,578 90.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m624640 97.5%   
Profit after tax Rs m1,7101,938 88.2%  
Gross profit margin %25.814.0 184.5%  
Effective tax rate %26.724.8 107.7%   
Net profit margin %10.810.9 99.0%  
BALANCE SHEET DATA
Current assets Rs m11,01814,431 76.4%   
Current liabilities Rs m9,5177,296 130.4%   
Net working cap to sales %9.440.0 23.6%  
Current ratio x1.22.0 58.5%  
Inventory Days Days57265 21.5%  
Debtors Days Days3251 1.4%  
Net fixed assets Rs m18,78717,347 108.3%   
Share capital Rs m161166 97.3%   
"Free" reserves Rs m14,35419,655 73.0%   
Net worth Rs m14,51619,820 73.2%   
Long term debt Rs m4,1896 74,412.1%   
Total assets Rs m29,80531,796 93.7%  
Interest coverage x3.564.1 5.4%   
Debt to equity ratio x0.30 101,607.5%  
Sales to assets ratio x0.50.6 95.1%   
Return on assets %8.96.2 143.1%  
Return on equity %11.89.8 120.5%  
Return on capital %17.513.2 132.7%  
Exports to sales %24.90-   
Imports to sales %3.78.5 44.2%   
Exports (fob) Rs m3,956NA-   
Imports (cif) Rs m5941,509 39.4%   
Fx inflow Rs m4,9523,259 151.9%   
Fx outflow Rs m6971,509 46.2%   
Net fx Rs m4,2551,749 243.2%   
CASH FLOW
From Operations Rs m2,7861,549 179.9%  
From Investments Rs m-1,529111 -1,373.1%  
From Financial Activity Rs m-941-1,800 52.3%  
Net Cashflow Rs m317-138 -228.7%  

Share Holding

Indian Promoters % 61.4 69.7 88.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 23.0 10.2 225.2%  
FIIs % 12.0 2.4 492.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 30.3 127.2%  
Shareholders   52,291 55,341 94.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Dishman Pharma vs FDC

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs FDC Share Price Performance

Period Dishman Pharma FDC S&P BSE HEALTHCARE
1-Day 2.87% 1.06% 1.18%
1-Month -2.45% -4.50% -0.75%
1-Year 96.38% 69.82% 61.82%
3-Year CAGR 89.34% 14.77% 18.16%
5-Year CAGR 38.20% 20.71% 19.79%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the FDC share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of FDC the stake stands at 69.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of FDC.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

FDC paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of FDC.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.